Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic dysfunction: The silenced connection with fatty liver disease
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, et al.
Annals of Hepatology (2023) Vol. 28, Iss. 6, pp. 101138-101138
Open Access | Times Cited: 19

Showing 19 citing articles:

Breaking new ground: MASLD vs. MAFLD—which holds the key for risk stratification?
Mariana M. Ramírez-Mejía, Carlos Jiménez-Gutiérrez, Mohammed Eslam, et al.
Hepatology International (2023) Vol. 18, Iss. 1, pp. 168-178
Closed Access | Times Cited: 54
Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease
Carmen Colaci, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, et al.
Hepatoma Research (2024) Vol. 10, pp. 16-16
Open Access | Times Cited: 13
Thyme, oregano, and rosemary: herbs and food supplements for the management of metabolic associated fatty liver disease
Hamza Elbouny, Ayoub Amssayef, Rania Benjamaa, et al.
Nutrire (2025) Vol. 50, Iss. 1
Closed Access | Times Cited: 1
Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study
Shan Hong, Ziyu Liu, Ping Li, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access | Times Cited: 1
Cardiovascular disease and metabolic dysfunction-associated steatotic liver disease: pathophysiology and diagnostic aspects
Søren Møller, Nina Kimer, Jens D. Hove, et al.
European Journal of Preventive Cardiology (2025)
Closed Access | Times Cited: 1
Impact of microplastics and nanoplastics on liver health: Current understanding and future research directions
Chun‐Cheng Chiang, Hsuan Yeh, Ruei-Feng Shiu, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 9, pp. 1011-1017
Open Access | Times Cited: 7
Prebiotic Treatment in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)—A Randomized Pilot Trial
Naama Reshef, Uri Gophna, Leah Reshef, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1571-1571
Open Access | Times Cited: 7
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis
Shudi Li, Fei Duan, Suling Li, et al.
Annals of Hepatology (2023) Vol. 29, Iss. 2, pp. 101174-101174
Open Access | Times Cited: 13
Nicotinamide Adenine Dinucleotide Phosphate Oxidases and Metabolic Dysfunction-Associated Steatotic Liver Disease
Vittoria Cammisotto, Emanuele Valeriani, Pasquale Pignatelli, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 83-83
Open Access
Inter- and Intraobserver variability of attenuation coefficient measurement in innovative ultrasound diagnosis of metabolic dysfunction-associated steatotic liver disease: a cross-sectional study
Maksym Zhaivoronok, Oleh Dynnyk, Olexandr Livkutnyk, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Evaluating the RESET care program: Advancing towards scalable and effective healthcare solutions for metabolic dysfunction-associated liver disease
Mariana M. Ramírez-Mejía, Froylan David Martínez‐Sánchez, Jacqueline Córdova-Gallardo, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 4
Closed Access
Metabolic dysfunction associated fatty liver disease in healthy weight individuals
Nahúm Méndez‐Sánchez, Willem Pieter Brouwer, Frank Lammert, et al.
Hepatology International (2024) Vol. 18, Iss. S2, pp. 884-896
Open Access | Times Cited: 3
Effect of Gracilaria vermiculophylla Macroalga on Non-Alcoholic Fatty Liver Disease in Obese Rats
Maitane González-Arceo, Leixuri Aguirre, M. T. Macarulla, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 369-369
Open Access | Times Cited: 1
Protein restriction associated with high fat induces metabolic dysregulation without obesity in juvenile mice
Amélie Joly, Jean‐Louis Thoumas, Anne Lambert, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Revolutionizing the understanding of liver disease: Metabolism, function and future
Arnulfo E Morales-Galicia, Mariana M. Ramírez-Mejía, Guadalupe Ponciano‐Rodríguez, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 12, pp. 1365-1370
Closed Access
Protein restriction associated with high fat induces metabolic dysregulation without obesity in juvenile mice
Amélie Joly, Jean‐Louis Thoumas, Anne Lambert, et al.
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access
Decoding MASLD’s Pathophysiology
Ludovico Abenavoli, Giuseppe Guido Maria Scarlata
(2024), pp. 15-24
Closed Access
Introduction of MASLD
Nahúm Méndez‐Sánchez, Mariana M. Ramírez-Mejía, Mohammed Eslam
(2024), pp. 1-6
Closed Access
Unveiling the MASLD Epidemic
Nahúm Méndez‐Sánchez, Mariana M. Ramírez-Mejía, Xingshun Qi
(2024), pp. 7-14
Closed Access
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis
Martina Maurelli, Paolo Gisondi, Francesco Bellinato, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 6057-6057
Open Access
Page 1

Scroll to top